{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:37:59Z","timestamp":1722890279392},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.juro.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:26:48Z","timestamp":1521386808000},"page":"335-343","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy"],"prefix":"10.1097","volume":"200","author":[{"given":"Laurence","family":"Klotz","sequence":"first","affiliation":[{"name":"Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Siemens","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Ouellette","sequence":"additional","affiliation":[{"name":"Division of Urology, Paul Ouellette Clinic, Granby, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Division of Urology, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Kebabdjian","sequence":"additional","affiliation":[{"name":"Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[{"name":"Division of Urology, Universit\u00e9 de Montreal, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Canadian Urology Research Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2018.03.010_bib1","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO;2-N","article-title":"Intermittent endocrine therapy for advanced prostate cancer","volume":"58","author":"Klotz","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2018.03.010_bib2","first-page":"2275","article-title":"Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma","volume":"50","author":"Bruchovsky","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2018.03.010_bib3","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z","article-title":"Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen","volume":"71","author":"Akakura","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2018.03.010_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0960-0760(96)00018-0","article-title":"Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model","volume":"58","author":"Sato","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.juro.2018.03.010_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2009.07.049","article-title":"Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature","volume":"57","author":"Abrahamsson","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2018.03.010_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaoncol.2015.2895","article-title":"Intermittent versus continuous androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"1","author":"Magnan","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.juro.2018.03.010_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1201546","article-title":"Intermittent androgen suppression for rising PSA level after radiotherapy","volume":"367","author":"Crook","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.03.010_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa1212299","article-title":"Intermittent versus continuous androgen deprivation in prostate cancer","volume":"368","author":"Hussain","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.03.010_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.eururo.2015.10.007","article-title":"Intermittent versus continuous androgen deprivation therapy in patients with relapsing or locally advanced prostate cancer: a phase 3b randomised study (ICELAND)","volume":"69","author":"Schulman","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2018.03.010_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eururo.2013.03.055","article-title":"Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uro-oncological Group","volume":"66","author":"Calais da Silva","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2018.03.010_bib11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaoncol.2016.3138","article-title":"Intermittent androgen deprivation therapy\u2014an important treatment option for prostate cancer","volume":"2","author":"Klotz","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.juro.2018.03.010_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/cncr.22464","article-title":"Locally advanced prostate cancer\u2013biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy","volume":"109","author":"Bruchovsky","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2018.03.010_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/pcan.2016.35","article-title":"A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients","volume":"19","author":"Jin","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2018.03.010_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamaoncol.2015.4655","article-title":"Adverse health events following intermittent and continuous androgen deprivation in patients with metastatic prostate cancer","volume":"2","author":"Hershman","year":"2016","journal-title":"JAMA Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718425025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718425025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2018.03.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:49:03Z","timestamp":1651211343000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2018.03.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1016\/j.juro.2018.03.010"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2018.03.010","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"type":"print","value":"0022-5347"},{"type":"electronic","value":"1527-3792"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}